RLMD
Relmada TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RLMD vs peer average
50/100
RLMD vs. peer average (C vs. C)
Grade spread
A 3 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
TLSI is the first available peer comparator.
TriSalus is only a loose comp, but it is another small-cap life-sciences name where valuation is driven more by clinical execution and financing cadence than current earnings.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RLMD
Relmada Therapeutics
TLSI
TriSalus Life Sciences
Grade
C
F
Momentum
24
62
Value
41
41
Sentiment
83
17
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs TLSI
RLMD / TLSI
Grade Position
In line
RLMD vs. peer average (C vs. C)
50/100
Momentum
24
TLSIValue
41
RLMDSentiment
83
RLMDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RLMD
TLSI is the first peer returned for this comparison set.